Your browser doesn't support javascript.
loading
The impact of rifampicin on the pharmacokinetics of fuzuloparib in healthy Chinese male volunteers.
Zhang, Qiao; Kai, Jiejing; Zhai, You; Xu, Nana; Shentu, Jianzhong; Zhang, Yanyan; Liang, Yanjuan; Wang, Yuya; Wu, Lihua.
Afiliação
  • Zhang Q; Research Center for Clinical Pharmacy, Zhejiang Provincial Key Laboratory for Drug Evaluation and Clinical Research, The First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang Province, Hangzhou, China.
  • Kai J; Research Center for Clinical Pharmacy, Zhejiang Provincial Key Laboratory for Drug Evaluation and Clinical Research, The First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang Province, Hangzhou, China.
  • Zhai Y; Research Center for Clinical Pharmacy, Zhejiang Provincial Key Laboratory for Drug Evaluation and Clinical Research, The First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang Province, Hangzhou, China.
  • Xu N; Research Center for Clinical Pharmacy, Zhejiang Provincial Key Laboratory for Drug Evaluation and Clinical Research, The First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang Province, Hangzhou, China.
  • Shentu J; Research Center for Clinical Pharmacy, Zhejiang Provincial Key Laboratory for Drug Evaluation and Clinical Research, The First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang Province, Hangzhou, China.
  • Zhang Y; Clinical Pharmacology Department, Jiangsu Hengrui Medicine Co. LTD., 1288 Haike Road, Pudong, Shanghai, China.
  • Liang Y; Clinical Operations Department, Jiangsu Hengrui Medicine Co. LTD., 1288 Haike Road, Pudong, Shanghai, China.
  • Wang Y; Clinical Pharmacology Department, Jiangsu Hengrui Medicine Co. LTD., 1288 Haike Road, Pudong, Shanghai, China.
  • Wu L; Research Center for Clinical Pharmacy, Zhejiang Provincial Key Laboratory for Drug Evaluation and Clinical Research, The First Affiliated Hospital, College of Medicine, Zhejiang University, Zhejiang Province, Hangzhou, China.
Br J Clin Pharmacol ; 88(1): 84-90, 2022 01.
Article em En | MEDLINE | ID: mdl-34033139
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rifampina / Indutores do Citocromo P-450 CYP3A Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans / Male País/Região como assunto: Asia Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rifampina / Indutores do Citocromo P-450 CYP3A Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Humans / Male País/Região como assunto: Asia Idioma: En Revista: Br J Clin Pharmacol Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China